Intrinsiqs

Is Pyxis Oncology, Inc. overvalued?

Pyxis Oncology, Inc. (PYXS) — key valuation metrics and fundamentals.

No verdict
Price
$3.01
Fair value
Current P/E
Normal P/E
Market cap
$190.7M
Dividend yield
0.0%
Return on equity
-135.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PYXS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.